Germacrone

CAS No. 6902-91-6

Germacrone ( Germacrone; Germacron )

Catalog No. M19001 CAS No. 6902-91-6

Germacrone, a major active component found in Curcuma zedoaria oil product, shows anti-inflammatory, antiandrogenic, and antivirus activities. It also inhibits the proliferation of glioma cells by promoting apoptosis.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 37 In Stock
10MG 67 In Stock
25MG 113 In Stock
50MG 146 In Stock
100MG 189 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Germacrone
  • Note
    Research use only, not for human use.
  • Brief Description
    Germacrone, a major active component found in Curcuma zedoaria oil product, shows anti-inflammatory, antiandrogenic, and antivirus activities. It also inhibits the proliferation of glioma cells by promoting apoptosis.
  • Description
    Germacrone, a major active component found in Curcuma zedoaria oil product, shows anti-inflammatory, antiandrogenic, and antivirus activities. It also inhibits the proliferation of glioma cells by promoting apoptosis.
  • Synonyms
    Germacrone; Germacron
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    Antiviral; CYP2B6; CYP3A4
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    6902-91-6
  • Formula Weight
    218.17
  • Molecular Formula
    C15H22O
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    C\1=C(/CC/C=C(/CC(=O)C(=C(C)C)C1)\C)\C
  • Chemical Name
    (3E,7E)-3,7-Dimethyl-10-(propan-2-ylidene)cyclodeca-3,7-dienone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xie XH, et al. Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med. 2014 Nov;8(5):1611-1615.
molnova catalog
related products
  • (S)-( )-Ibuprofen

    An enantiomer of Ibuprofen that more potently inhibits COX activity, thromboxane formation, and platelet aggregation than the (R)-form.

  • Ketorolac

    Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) in the family of heterocyclic acetic acid derivatives. It acts by inhibiting the bodily synthesis of prostaglandins.

  • Etoricoxib

    Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).